| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 61 |
| 1 | BEVACIZUMAB | 43 |
| 2 | SPIRONOLACTONE | 42 |
| 3 | OXALIPLATIN | 35 |
| 4 | LANSOPRAZOLE | 31 |
| 5 | LACTULOSE | 22 |
| 6 | ACETAMINOPHEN | 21 |
| 7 | ASPIRIN | 21 |
| 8 | OMEPRAZOLE MAGNESIUM | 21 |
| 9 | ATEZOLIZUMAB | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TERLIPRESSIN | 5 | 0.0151 |
| 1 | FLOXURIDINE | 1 | 0.0058 |
| 2 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 3 | ARFORMOTEROL TARTRATE | 1 | 0.0042 |
| 4 | BACTERIOSTATIC WATER | 1 | 0.0024 |
| 5 | IXABEPILONE | 2 | 0.0019 |
| 6 | ORPHENADRINE CITRATE | 1 | 0.0016 |
| 7 | ADEFOVIR DIPIVOXIL | 2 | 0.0016 |
| 8 | ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID | 1 | 0.0016 |
| 9 | ETHIODIZED OIL | 2 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 63 |
| 1 | Proton Pump Inhibitor [EPC] | 53 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 44 |
| 3 | Corticosteroid [EPC] | 43 |
| 4 | Aldosterone Antagonist [EPC] | 42 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 41 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 40 |
| 7 | Platinum-based Drug [EPC] | 38 |
| 8 | beta-Adrenergic Blocker [EPC] | 34 |
| 9 | Osmotic Laxative [EPC] | 30 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin Receptor Agonist [EPC] | 5 | 0.0151 |
| 1 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 2 | Thyroid Hormone Receptor beta Agonist [EPC] | 2 | 0.0009 |
| 3 | Leptin Analog [EPC] | 1 | 0.0008 |
| 4 | Provitamin D2 Compound [EPC] | 20 | 0.0007 |
| 5 | Prostacyclin Receptor Agonist [EPC] | 13 | 0.0005 |
| 6 | Bile Acid [EPC] | 11 | 0.0005 |
| 7 | Rifamycin Antibacterial [EPC] | 15 | 0.0004 |
| 8 | alpha-Glucosidase Inhibitor [EPC] | 2 | 0.0004 |
| 9 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0004 |